Ultimate Solution Hub

Overall Survival Rate In All Patients According To Influencing Factors

overall Survival Rate In All Patients According To Influencing Factors
overall Survival Rate In All Patients According To Influencing Factors

Overall Survival Rate In All Patients According To Influencing Factors Of the 1387 patients identified, 301 (21.7%) had developed recurrence or relapse. the 5 year overall recurrence for all stage i patients was 20.2% (fig. 1b). table 1 presented results of univariate and multivariate analyses of overall survival and overall recurrence according to clinicopathologic characteristics of patients with stage i nsclc. The 5 year overall survival rate was 20.3% (25 123). adjusted analysis of prognostic factors influencing the 5 year overall survival of hos. the outcomes and prognostic factors in patients.

overall Survival Rate In All Patients According To Influencing Factors
overall Survival Rate In All Patients According To Influencing Factors

Overall Survival Rate In All Patients According To Influencing Factors Older patients were attributed higher mortality estimates 14 and were more likely to be viewed as receiving futile treatment, 6 correlating with higher actual mortality. 6 patients with multiple comorbidities had a less favorable survival prognosis. 60 quality of life prognosis was also dependent on the patient’s disease characteristics, such. Ational metastatic renal cell carcinoma database consortium (imdc) models. data of 790 patients diagnosed with mrcc and receiving targeted therapy as their first line treatment were pooled to this study. data from 4 hospitals (n = 619) were used to develop the new model and those from other 5 hospitals (n = 171) were used for external validation. after detecting prognostic factors in. The current study assesses the influence of risk factors on the 5 year overall survival in stage ib1 iib cervical cancer patients who underwent radical hysterectomy followed by adjuvant ccrt in a 9 year follow up study at a tertiary care center in eastern europe, allowing comparisons with other regions. Background breast cancer related leptomeningeal disease (bc lmd) is a dire diagnosis for 5–8% of patients with breast cancer (bc). we conducted a retrospective review of bc lmd patients diagnosed at moffitt cancer center from 2011 to 2020, to determine the changing incidence of bc lmd, factors which are associated with the progression of bc cns metastasis to bc lmd, and factors which are.

Comments are closed.